[Federal Register: September 26, 2008 (Volume 73, Number 188)]
[Notices]               
[Page 55869]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26se08-84]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 28, 2008, Mallinckrodt 
Inc., 3600 North Second Street, St. Louis, Missouri 63147, made 
application by letter to the Drug Enforcement Administration (DEA) as a 
bulk manufacturer of Oripavine (9330), a basic class of controlled 
substance listed in schedule II.
    The company plans to use the above listed controlled substance as 
an intermediate in the manufacture of a non-controlled product.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than November 25, 2008.

    Dated: September 18, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-22696 Filed 9-25-08; 8:45 am]

BILLING CODE 4410-09-P